MedTrace Logo

Comparative Effectiveness of COPD Treatments

NCT03376295 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3954

Last updated 2019-07-24

Study results available
· View outcomes & findings →

Summary

To assess the effectiveness of maintenance treatment of Chronic obstructive pulmonary disease (COPD) with the combination of a long-acting bronchodilators (LABA and the long-acting muscarinic antagonists (LAMA) tiotropium (LABA-TIO)) compared with the combination of a LABA and an ICS (LABA-ICS) on the time to COPD exacerbation.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

LABA and the LAMA tiotropium (LABA-TIO)

combinational drug

DRUG

LABA and an ICS (LABA-ICS)

combinational drug

Sponsors & Collaborators

Eligibility

Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2017-12-31
Completion
2017-12-31
FDA Drug
Yes

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03376295 on ClinicalTrials.gov